Oligonucleic acid variant libraries and synthesis thereof

Patent metadata

Field	Value
Publication number	US-10844373-B2
Application number	US-201615268422-A
Country	US
Kind code	B2
Filing date	Sep 16, 2016
Priority date	Sep 18, 2015
Publication date	Nov 24, 2020
Grant date	Nov 24, 2020

Abstract

Disclosed herein are methods for the generation of highly accurate oligonucleic acid libraries encoding for predetermined variants of a nucleic acid sequence. The degree of variation may be complete, resulting in a saturated variant library, or less than complete, resulting in a selective library of variants. The variant oligonucleic acid libraries described herein may designed for further processing by transcription or translation. The variant oligonucleic acid libraries described herein may be designed to generate variant RNA, DNA and/or protein populations. Further provided herein are method for identifying variant species with increased or decreased activities, with applications in regulating biological functions and the design of therapeutics for treatment or reduction of disease.

First claim

What is claimed is:

1. A method for generating a protein library, the method comprising:
a) providing at least 500 predetermined nucleic acid sequences, wherein the at least 500 predetermined nucleic acid sequences encode for 19 variants for each position of multiple codon positions compared to a single template sequence;
b) synthesizing a plurality of oligonucleotides, wherein the plurality of oligonucleotides encode for sequences provided in the at least 500 predetermined nucleic acid sequences;
c) mixing the plurality of oligonucleotides with a DNA polymerase and the single template sequence to form a library of variant nucleic acids, wherein the library of variant nucleic acids encodes for about 99% of the at least 500 predetermined nucleic acid sequences; and
d) transferring the library of variant nucleic acids to cells and expressing a plurality of variant proteins.

2. The method of claim 1 , wherein the at least 500 predetermined nucleic acid sequences comprise different predetermined ratios of codon sequence variance for each of the multiple codon positions.

3. The method of claim 1 , wherein the at least 500 predetermined nucleic acid sequences comprise different predetermined ratios of codon sequence variance for at least 5 codon positions.

4. The method of claim 1 , wherein the library of variant nucleic acids comprises nucleic acids encoding for a variant codon sequence in at least two adjacent codon positions compared to the single template sequence.

5. The method of claim 1 , wherein the library of variant nucleic acids comprises nucleic acids encoding for a variant codon sequence in at least two non-adjacent codon positions compared to the single template sequence.

6. The method of claim 1 , wherein the cells are eukaryotic cells or prokaryotic cells.

7. The method of claim 1 , wherein the library of variant nucleic acids encodes sequences for variant genes or fragments thereof.

8. The method of claim 1 , wherein a variant protein of the plurality of variant proteins is an antibody, enzyme or peptide.

9. The method of claim 8 , wherein the antibody is an antibody fragment.

10. The method of claim 9 , wherein the antibody fragment is a Fab, Fab', F(ab')2, Fv, diabody, linear antibody, single-chain antibody, or multispecific antibody.

11. The method of claim 8 , wherein the antibody is an antibody region.

12. The method of claim 11 , wherein the antibody region is a Fc region, Fab region, variable region of a Fab region, constant region of a Fab region, variable domain of a heavy chain, variable domain of a light chain, specific complementarity-determining region (CDR) of a variable heavy chain, or specific CDR of a variable light chain.

13. The method of claim 1 , wherein at least 5,000 predetermined nucleic acid sequences are provided.

14. The method of claim 1 , wherein at least 10,000 predetermined nucleic acid sequences are provided.

15. The method of claim 1 , wherein at least 100,000 predetermined nucleic acid sequences are provided.

16. The method of claim 1 , wherein each of the at least 500 predetermined nucleic acid sequences comprises at least 20 bases in length.

17. The method of claim 1 , wherein each of the at least 500 predetermined nucleic acid sequences comprises at least 100 bases in length.

18. The method of claim 1 , wherein each of the at least 500 predetermined nucleic acid sequences comprises predetermined ratios of codon sequence variance for multiple codon positions compared to the single reference template sequence.

19. The method of claim 1 , wherein the library of variant nucleic acids encodes for about 99% of the at least 500 predetermined nucleic acid sequences following amplification.

Assignees

• Twist Bioscience Corp

Inventors

• Cox Anthony
• Treusch Sebastian
• Chen Siyuan

Classifications

• G01N33/5041

  involving analysis of members of signalling pathways · CPC title

• G01N33/5029

  on cell motility · CPC title

• G01N33/502

  for testing non-proliferative effects · CPC title

• C40B50/14

  Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support · CPC title

• C40B50/08

  Liquid phase synthesis, i.e. wherein all library building blocks are in liquid phase or in solution during library creation; Particular methods of cleavage from the liquid support · CPC title